Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results March 5, 2026 Topline results for Phase 2 SANRECO trial of divesiran, a first-in-class siRNA for polycythemia vera (PV), on-track for third quarter of 2026
Algoma Central Corporation Reports Financial Results for Fiscal 2025 March 5, 2026 Strong momentum continues in 2025 through resilient performance and strategic fleet growth across global and domestic markets
Techtronic Industries Delivers Solid Performance in 2025 March 3, 2026 Growing Sales to US$15.3 Billion, Net Profit Increased to US$1.2 Billion
RHI Magnesita 2025 Full Year Results: Disciplined Execution and Strong H2 Performance Deliver Resilient Earnings in Challenging Market Environment March 2, 2026 RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, announces its results for the year ended 31 December 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302341332/en/ A resilient financial performance – in line with expectations Against a challenging market backdrop, RHI Magnesita delivered a performance in line [...]
SES: Full Year 2025 Results March 2, 2026 SES S.A. fully consolidates Intelsat from 17 July 2025 and announces financial results for the year ended 31 December 2025 FY25 Performance (€ million) 2025 as reported (1) 2024 as reported (1) ∆ at constant FX (2) 2025 like-for-like (3) 2024 like-for-like (3) ∆ at constant FX (2) Average €/$ FX rate 1.12 1.09 [...]
Fluidra Delivers Strong 2025 Results, Advancing Its Strategic Priorities February 26, 2026 Sales up 7% on constant currency to €2,184 million with volume growth across all regions and positive price contribution Net income of €176 million, up 28% Successful completion of the €100 million savings set under its Simplification Plan Proposes 2025 dividend distribution of 65 euro cents per share, up 8%
Allianz Achieves Record Operating Profit of 17.4 Billion Euros – Excellent Start to New Strategic Cycle February 26, 2026 12M 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225107874/en/ Excellent momentum and record operating profit Total business volume rises 8.11 percent and reaches 186.9 billion euros with contributions from all segments Operating profit increases 8.4 percent to 17.4 billion euros, our highest operating profit ever Shareholders’ core net income advances 10.9 [...]
Indra Group Exceeds All Its Guidances in 2025 and Sets Even More Ambitious Guidances for 2026 Than Those Set Out in Its ‘Leading the Future’ Strategic Plan February 25, 2026 Results in fiscal year 2025 Revenues increased by 13%, totaling €5.457 billion in 2025 Indra Group sets financial guidances at least 17% higher than those foreseen in its Strategic Plan for 2026 Indra Group announces the payment of a €0.30 dividend per share (more than 20% above the dividend in 2024) charged to the earnings posted in 2025 The results and the increase in the order intake confirm Indra Group’s industrial strength and its capacity to tackle and execute the major defence modernization programs
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 February 25, 2026 Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter and year ended Dec. 31, 2025 and provided financial expectations for 2026. To view the detailed fourth quarter and full year 2025 earnings press release and presentation please visit the company’s investor relations website at https://investor.alkermes.com. Alkermes will host a conference call and webcast [...]
Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025 February 25, 2026 Strong margin improvement to 16.3% in FY 2025 Positive growth outlook with continued margin expansion in 2026 New EUR 200 million share buyback